Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJA9R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,713
Award facts
- Contract value 100% obligated
- $14,713.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,713.26 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injections. This competitive, non-set-aside contract was executed on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under a firm fixed-price structure, typical of the DLA's medical supply procurement methodology.
This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains a robust portfolio of federal medical procurement contracts, supplying a comprehensive range of pharmaceuticals and medical supplies to support military healthcare systems and the Defense Health Agency. The Dupixent order fulfills ongoing pharmaceutical supply needs within the DLA's global medical support operations, consistent with the company's extensive experience delivering brand-name and specialized medications across multiple therapeutic domains to federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26FJA9R?
SPE2DR26FJA9R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FJA9R worth?
The government has obligated $14,713 on SPE2DR26FJA9R.
Is contract SPE2DR26FJA9R an order under another contract?
Yes. SPE2DR26FJA9R is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJA9R competed?
The extent of competition for SPE2DR26FJA9R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award